Clinical Trials Directory

Trials / Completed

CompletedNCT07107854

EVALUATION OF THE EFFICACY OF COSMETIC PRODUCT IN ADULTS SUBJECTS WITH MILD TO MODERATE ACNE

EVALUATION OF THE EFFICACY OF COSMETIC PRODUCT IN ADULTS SUBJECTS WITH MILD TO MODERATE ACNE - USE TEST UNDER DERMATOLOGICAL CONTROL - MULTICENTER STUDY

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
Cosmetique Active International · Industry
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

EVALUATION OF THE EFFICACY OF COSMETIC PRODUCT IN ADULTS SUBJECTS WITH MILD TO MODERATE ACNE. USE TEST UNDER DERMATOLOGICAL CONTROL. THE STUDY CONDUCTED IN POLAND AND MAURITIUS

Detailed description

Claims: * Improvement of acne * Improvement of skin smoothness parameters Objectives: To evaluate: * Its capacity to maintain the human face in good condition (cutaneous acceptability) by clinical examination under dermatological control; * their comedogenic potential by counting the retentional and inflammatory lesions by the dermatologist in charge of the study; * its smoothing effect by collecting polymer silicone skin's prints Silflo® and analysis using 3D Primos® Compact System * its capacity to improve skin elasticity using cutometer® * its capacity to maintain skin hydration using corneometer® * its effect on the skin state by clinical scoring by the dermatologist in charge of the study; * its effect on skin state by clinical auto scoring by the subjects; * their anti-acne effect by GEA score and AFAST (score B) by the dermatologist in charge of the study; * to illustrate their visual expected effect using ColorFace® and skincam®; * to evaluate the change of subjects' quality of life questionnaire (AI-ADL) from baseline to D84 and D168; * subjectively its cosmetic acceptability, properties, efficacy and future use by analysis of the subjects' answers to a subjective evaluation questionnaire

Conditions

Interventions

TypeNameDescription
OTHERcosmetic: EFFACLAR ULTRA CONCENTRATED SERUMTransparent solution (gel)

Timeline

Start date
2023-02-15
Primary completion
2024-01-26
Completion
2024-01-26
First posted
2025-08-06
Last updated
2025-08-06

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT07107854. Inclusion in this directory is not an endorsement.